The Current Status of Non-Biopharma Drug Discovery
Posted in Archive
| Tagged Academic, ADME / Tox, AI / data analytics / healthtech / informatics, Analysis, Assay development optimisation & technology, Automation / robotics, Biochemistry, Biologics / Biotechnology, Business, Cell culture, Cellular assays, Chemistry, Clinical trials, Drug development, Drug discovery, Drug targets, Enabling technologies, High Content Screening, High throughput screening, Imaging, Immunology, In Silico Biology, Lead discovery, Lead optimisation, Oncology, Pharmacology, Preclinical, RNA, Screening, System biology, Systems biology, Target validation
